Laddar...
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
Over the past 15 years, three new classes of drugs, glucagon‐like peptide‐1 (GLP‐1) receptor agonists, dipeptidyl peptidase 4 (DPP‐4) inhibitors and sodium glucose cotransporter‐2 (SGLT‐2) inhibitors have been approved to treat type 2 diabetes based on effects on glycemic control. Although large ran...
Sparad:
| I publikationen: | Diabetes Obes Metab |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Blackwell Publishing Ltd
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6220800/ https://ncbi.nlm.nih.gov/pubmed/30294953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13453 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|